Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study.

OBJECTIVE Controversy remains regarding the association between type 2 diabetes mellitus (DM) and colorectal cancer (CRC) risk. To clarify and extend the existing data, we prospectively evaluated the association between self-reported type 2 DM (onset at >30 years of age) and incident CRC, overall and by anatomic subsite, among postmenopausal women in the Iowa Women's Health Study (n = 35,230). METHODS After 14 years of follow-up, a total of 870 incident CRC cases were identified through annual linkage to the Iowa Cancer Registry. DM was analyzed as reported at baseline and as a time-dependent variable using information obtained during follow-up. CRC risks were estimated using Cox proportional hazards regression models. RESULTS After adjusting for age, body mass index and other potential confounding variables, the relative risk (RR) for women with DM versus women without DM was modestly increased at 1.4 [95% confidence interval (95% CI), 1.1-1.8]. By anatomic subsite, the RR for proximal colon cancer was statistically significantly increased (RR, 1.9; 95% CI, 1.3-2.6), whereas the RRs for distal colon (RR, 1.1; 95% CI, 0.6-1.8) and rectal cancer (RR, 0.8; 95% CI, 0.4-1.6) were not statistically different from unity. Analyses that included DM ascertained at baseline and follow-up yielded similar results. CONCLUSION In this large, prospective study of postmenopausal women, the association between DM and incident CRC was found to be subsite specific. If confirmed by others, this finding implies that CRC prevention strategies among type 2 DM patients should include examination of the proximal colon.

[1]  N. Cook,et al.  Dietary glycemic load and risk of colorectal cancer in the Women's Health Study. , 2004, Journal of the National Cancer Institute.

[2]  I. Sobhani,et al.  Leptin reduces the development of the initial precancerous lesions induced by azoxymethane in the rat colonic mucosa. , 2004, Gastroenterology.

[3]  W. Willett,et al.  Comparison of risk factors for colon and rectal cancer , 2004, International journal of cancer.

[4]  D. Silverman,et al.  Cancer risk in patients with diabetes mellitus , 1991, Cancer Causes & Control.

[5]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[6]  E. Riboli,et al.  Plasma insulin, IGF‐binding proteins‐1 and ‐2 and risk of colorectal cancer: A prospective study in Northern Sweden , 2003, International journal of cancer.

[7]  S. Bell,et al.  Low-Glycemic-Load Diets: Impact on Obesity and Chronic Diseases , 2003, Critical reviews in food science and nutrition.

[8]  A. Miller,et al.  Glycemic load, carbohydrate intake, and risk of colorectal cancer in women: a prospective cohort study. , 2003, Journal of the National Cancer Institute.

[9]  J. Brand-Miller.  Glycemic load and chronic disease. , 2003, Nutrition reviews.

[10]  J. Cerhan,et al.  Cigarette smoking and colorectal cancer: long-term, subsite-specific risks in a cohort study of postmenopausal women. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[11]  N. Rifai,et al.  Association of markers of insulin and glucose control with subsequent colorectal cancer risk. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[12]  J. Gerich.  Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. , 2003, Mayo Clinic proceedings.

[13]  R. Henry.  Insulin resistance: from predisposing factor to therapeutic target in type 2 diabetes. , 2003, Clinical therapeutics.

[14]  A. Hokama,et al.  Relationship Between Diabetes Mellitus and the Site of Colorectal Cancer , 2003, American Journal of Gastroenterology.

[15]  W. R. Bruce,et al.  Direct measure of insulin sensitivity with the hyperinsulinemic-euglycemic clamp and surrogate measures of insulin sensitivity with the oral glucose tolerance test: correlations with aberrant crypt foci promotion in rats. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  Edward Giovannucci,et al.  Modifiable risk factors for colon cancer. , 2002, Gastroenterology clinics of North America.

[17]  C. la Vecchia,et al.  Diabetes mellitus, family history, and colorectal cancer , 2002, Journal of epidemiology and community health.

[18]  Preventive-care practices among persons with diabetes--United States, 1995 and 2001. , 2002, MMWR. Morbidity and mortality weekly report.

[19]  J. Fulton,et al.  Subsite‐specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992–1997 , 2001, Cancer.

[20]  E. Giovannucci.  Insulin, insulin-like growth factors and colon cancer: a review of the evidence. , 2001, The Journal of nutrition.

[21]  I. Tomlinson,et al.  Microsatellite instability and the clinicopathological features of sporadic colorectal cancer , 2001, Gut.

[22]  E. Paskett,et al.  Colorectal cancer screening in North Carolina: associations with diabetes mellitus and demographic and health characteristics. , 2001, Preventive medicine.

[23]  L. Vatten,et al.  Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis , 2001, British Journal of Cancer.

[24]  A. Lindblom.  Different mechanisms in the tumorigenesis of proximal and distal colon cancers , 2001, Current opinion in oncology.

[25]  T. Rohan,et al.  The relation of type 2 diabetes and cancer. , 2001, Diabetes technology & therapeutics.

[26]  C. Russell,et al.  Regulation of leptin production in humans. , 2000, The Journal of nutrition.

[27]  E. Riboli,et al.  Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. , 2000, Journal of the National Cancer Institute.

[28]  N. Calonge,et al.  Validation of self-reported chronic conditions and health services in a managed care population. , 2000, American journal of preventive medicine.

[29]  W. Willett,et al.  A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  M. Stampfer,et al.  A prospective study of plasma levels of insulin-like growth factor I (IGF-I) and IGF-binding protein-3, and colorectal cancer risk among men. , 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[31]  A. Renehan,et al.  Response: More About: Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF- Binding Protein-3 , 1999 .

[32]  L H Kuller,et al.  Increased blood glucose and insulin, body size, and incident colorectal cancer. , 1999, Journal of the National Cancer Institute.

[33]  S. Devesa,et al.  Incidence of colorectal carcinoma in the U.S. , 1999, Cancer.

[34]  G A Colditz,et al.  Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. , 1999, Journal of the National Cancer Institute.

[35]  Stampfer,et al.  Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. , 1999, Journal of the National Cancer Institute.

[36]  E. Calle,et al.  Colorectal cancer: another complication of diabetes mellitus? , 1998, American journal of epidemiology.

[37]  A. Børresen-Dale,et al.  Different genetic pathways to proximal and distal colorectal cancer influenced by sex‐related factors , 1997, International journal of cancer.

[38]  C. la Vecchia,et al.  Diabetes mellitus and colorectal cancer risk. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[39]  L. Kolonel,et al.  Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. , 1997, Cancer research.

[40]  J. Potter,et al.  Dietary sugar and colon cancer. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[41]  J. Girard,et al.  Is leptin the link between obesity and insulin resistance? , 1997, Diabetes & metabolism.

[42]  A. Green,et al.  Cancer and diabetes ‐ a follow‐up study of two populationbased cohorts of diabetic patients , 1997, Journal of internal medicine.

[43]  H. Adami,et al.  Diabetes mellitus and risk of large bowel cancer. , 1997, Journal of the National Cancer Institute.

[44]  T. Sellers,et al.  Physical activity and mortality in postmenopausal women. , 1997, JAMA.

[45]  A. Medline,et al.  Insulin promotion of colon tumors in rats. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[46]  M. Harris.  Chapter 2 Classification , Diagnostic Criteria , and Screening for Diabetes , 1996 .

[47]  K. Steenland,et al.  Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[48]  G. McKeown-Eyssen.  Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[49]  T. Sellers,et al.  Mortality and cancer rates in nonrespondents to a prospective study of older women: 5-year follow-up. , 1994, American journal of epidemiology.

[50]  R. Hultcrantz,et al.  Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29. , 1993, Scandinavian journal of gastroenterology.

[51]  M. Marmot,et al.  Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men. , 1992, American journal of epidemiology.

[52]  K. Midthjell,et al.  Is questionnaire information valid in the study of a chronic disease such as diabetes? The Nord-Trøndelag diabetes study. , 1992, Journal of epidemiology and community health.

[53]  K. Anderson,et al.  Serum cholesterol level, body mass index, and the risk of colon cancer. The framingham study , 1992, Cancer.

[54]  J. Potter,et al.  Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. , 1990, American journal of epidemiology.

[55]  T. Tsuruo,et al.  Insulin and Insulin‐like Growth Factor 1 Stimulate Proliferation of Metastatic Variants of Colon Carcinoma 26 , 1989, Japanese journal of cancer research : Gann.

[56]  A. Folsom,et al.  Accuracy and reliability of self-measurement of body girths. , 1988, American journal of epidemiology.

[57]  W. Willett,et al.  The use of a self-administered questionnaire to assess diet four years in the past. , 1988, American journal of epidemiology.

[58]  L. Melton,et al.  Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. , 1982, Journal of chronic diseases.

[59]  A. Belanger,et al.  The Framingham study. , 1976, British medical journal.

[60]  I. I. Kessler.  Cancer mortality among diabetics. , 1970, Journal of the National Cancer Institute.